Ventana Biotech, Inc. (VNTA) is a Shell Companies company in the Financial Services sector, currently trading at $0.04. It has a SharesGrow Score of 56/100, indicating a above average investment profile with 2 out of 7 criteria passed.
Financials: revenue is $41,362, +29.9%/yr average growth. Net income is $19,890, growing at +68.1%/yr. Net profit margin is 48.1% (strong). Gross margin is 0% (+0 pp trend).
Balance sheet: total debt is $109,617 with negative equity of -$52,334 — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.54 (tight liquidity). Debt-to-assets is 176.8%. Total assets: $62,005.
SharesGrow 7-Criteria breakdown: Value 15/100 (Fail), Growth 100/100 (Pass), Past 67/100 (Partial), Health 50/100 (Partial), Moat 11/100 (Fail), Future ?/100 (Fail), Income 100/100 (Pass).
